US$ 26.98
combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline Can dipeptidyl peptidase‑4 (DPP‑4) inhibitors be combined semaglutide ( GLP‑1 agonist)? Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
Saint Denis (France): HAS
Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: a single-center study

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

GIP receptor agonists are thought to have limited potential as sole therapy for DMT2, although further investigation is ongoing
